Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04385394 · ClinicalTrials.gov registry record
Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 100
- Enrollment target
NCT04385394 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 100 participants.
The verdict
NCT04385394 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to explore if Bright Light Therapy (BLT) as augmentation of depression treatment on an acute psychiatric floor is feasible, helps alleviate depressive symptoms, improve functioning, and decrease length of stay on the psychiatric floor.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2020-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04385394
The ClinicalTrials.gov registry entry for NCT04385394 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04385394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04385394 about?
NCT04385394 is a clinical study titled "Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor". The purpose of this study is to explore if Bright Light Therapy (BLT) as augmentation of depression treatment on an acute psychiatric floor is feasible, helps alleviate depressive symptoms, improve functioning, and decrease length of stay on the psychiatric floor.
What is the current status of trial NCT04385394?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-01-30. Estimated completion is 2020-08-20.
Who is sponsoring clinical trial NCT04385394?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.